USFDA completes surveillance inspection of Suven Pharmaceuticals’ arm

15 Jul 2024 Evaluate

United States Food & Drug Administration (USFDA) has completed the surveillance inspection of Suven Pharmaceuticals’ Wholly Owned Subsidiary -- Casper Pharma. The inspection took place from July 8, 2024, to July 12, 2024. Following the inspection, USFDA issued a Form 483 with two observations, which are procedural in nature. 

Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

Cohance Lifesciences Share Price

386.55 2.35 (0.61%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×